Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria - Concepedia

Concepedia

Publication | Closed Access

Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria

337

Citations

25

References

2017

Year

Mélodie Tazdait, Laura Mezquita, J. Lahmar, Roberto Ferrara, François Bidault, Samy Ammari, Corinne Balleyguier, David Planchard, Anas Gazzah, Jean‐Charles Soria,

European Journal of Cancer

OncologyMedicineRecist 1.1Metastatic NsclcImmune Checkpoint InhibitorPharmacotherapyPdl-1 Inhibitor TherapyCancer TreatmentPharmacology

References

	Year	Citations

Page 1

Page 1